Canbiola, Inc. (OTC PINK: CANB) Revenue and Shareholder 2nd Quarter Update
July 09, 2018 09:00 ET
|
Canbiola, Inc.
HICKSVILLE, NY. , July 09, 2018 (GLOBE NEWSWIRE) -- Canbiola, Inc. (OTC PINK: CANB) Canbiola is pleased to update shareholders on our progress for the first half of 2018. REVENUES: We expect...
Uptick Newswire Welcomes William Hartman, CEO of Premier Biomedical, Inc. Back on to the “Stock Day” Podcast
June 04, 2018 08:00 ET
|
Premier Biomedical, Inc.
PHOENIX, June 04, 2018 (GLOBE NEWSWIRE) -- William Hartman, CEO of Premier Biomedical, Inc. (OTC Pink:BIEI) (“the Company”) was recently interviewed by Marcus Heatherly on Uptick Newswire’s “Stock...
BioDelivery Sciences to Present at the William Blair 2018 Growth Stock Conference
June 01, 2018 08:00 ET
|
BioDelivery Sciences International, Inc.
RALEIGH, N.C., June 01, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc., (NASDAQ:BDSI), a leading specialty pharmaceutical company in the field of pain management and addiction...
BioDelivery Sciences to Present at the Jefferies 2018 Global Healthcare Conference
May 23, 2018 08:00 ET
|
BioDelivery Sciences International, Inc.
RALEIGH, N.C., May 23, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc., (NASDAQ:BDSI), a specialty pharmaceutical company with a focus in pain management and addiction medicine,...
BioDelivery Sciences Announces Closing of $50 Million Equity Financing and Appointment of Peter Greenleaf as Chairman of the Board
May 22, 2018 08:29 ET
|
BioDelivery Sciences International, Inc.
RALEIGH, N.C., May 22, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ:BDSI) today announced it has closed its previously announced $50 million registered direct offering...
BioDelivery Sciences Announces Agreement with Broadfin Capital on Comprehensive Plan to Strengthen Business
May 17, 2018 08:01 ET
|
BioDelivery Sciences International, Inc.
$50 Million Equity Financing Led By Broadfin Announced Separately Today Three New Independent Directors Selected by Broadfin Added To Board; Four Current Independent Directors Retiring Amends...
Endonovo Therapeutics Signs Distribution Agreement with Plagens Medical Consultants for its Pain Relief Electroceutical™ SofPulse®
May 09, 2018 13:30 ET
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA, May 09, 2018 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of Electroceutical™ Therapies, today...
Cleartronic, Inc. (CLRI) Subsidiary VoiceInterop Signs Definitive Agreement Acquiring the Assets of CanniPlus Global, Inc.
April 24, 2018 09:00 ET
|
Cleartronic, Inc.
SUBSIDIARY VOICEINTEROP, INC. TO BE SPUN OFF IN A FORM 10 AND S-1 REGISTRATION WITH THE SECURITIES AND EXCHANGE COMMISSION BOCA RATON, Fla., April 24, 2018 (GLOBE NEWSWIRE) -- Cleartronic, Inc.,...
CB Scientific’s (CBSC) R & D Focuses on Opioid Crisis, a National Public Health Emergency
October 31, 2017 08:00 ET
|
CB Scientific Inc
Denver, CO, Oct. 31, 2017 (GLOBE NEWSWIRE) -- CB Scientific, Inc. (OTC PINK: CBSC), a designer, developer and manufacturer of Cannabis Analytical Tools and Devices, Cannabis Medical Delivery Systems...
SPR Therapeutics® Secures $25 Million in Series C Financing
September 12, 2017 08:03 ET
|
SPR Therapeutics, LLC
CLEVELAND, Sept. 12, 2017 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc., (SPR) a private medical device company that has developed a novel neurostimulation technology for chronic and acute pain,...